An observational study on growth in HIV-infected children and adolescents on antiretroviral therapy in Europe, with special reference to darunavir (TMC114-EPPICC)

20/05/2015
31/03/2024
EU PAS number:
EUPAS9708
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

TMC114-EPPICC growth CTP[1]

English (376.13 KB - PDF) View document
Study results
Study results

TMC114_EPPICC_Darunavir_Growth_Final_Study_Report_2017_08_18

English (4.15 MB - PDF) View document
Study report
Other information